Novartis and Roche enjoy pharma-industry leading 2024 revenues. They also lead in total international patent volume. But Roche, with more oncology-specific patents for cancer treatment
Novartis and Roche enjoy pharma-industry leading 2024 revenues. They also lead in total international patent volume. But Roche, with more oncology-specific patents for cancer treatment